Merck posts two Phase 3 trials, sotatercept in HFpEF and sac-TMT in bladder cancerSep 24Weekly roundup, 4 itemsMerck & Co., Inc.sotatercept-csrk
Merck posts three JANUMET-family label updates; TERN-601 obesity data still stands outAug 11Weekly roundup, 4 itemsertugliflozin and metformin hydrochlorideMerck & Co., Inc.